Skip to main content
Premium Trial:

Request an Annual Quote

OncoGenome Sciences Inks $15.4M First Round

OncoGenome Sciences of Liege, Belgium, today announced a $15.4 million first-round funding led by Brank Brussels Lambert and a syndicate of European investors.


OncoGenome, founded in 2002 by Herman Spolders, a former vice president of business development and operations at Virco and headquartered at the medical school of the University of Liege, Belgium, is developing genomics-based diagnostic tests for cancer. The company has a US facility in Durham, NC.


Participating in the funder were PolyTechnos Venture-Partners of Munich, Germany; Life Sciences Partners of Amsterdam, Netherlands; and Belgium-based economic development investors: Technowal of Liege; Meusinvest of Liege; and SIBL, also of Liege, OncoGenome said in a statement.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.